Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Aug 8:10:980152.
doi: 10.3389/fchem.2022.980152. eCollection 2022.

Editorial: Serine protease inhibitors and their therapeutic applications

Letizia Crocetti  1 , Mark T Quinn  2 , Agostino Cilibrizzi  3 , Maria Paola Giovannoni  1
Affiliations
Editorial

Editorial: Serine protease inhibitors and their therapeutic applications

Letizia Crocetti et al. Front Chem. .
No abstract available

Keywords: drug design; inhibitors; molecular modeling (MD); organic synthesis; serine proteases.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the ResearchTopic Serine protease inhibitors and their therapeutic applications

References

    1. Ceuleers H., Hanning N., Heirbaut J., Van Remoortel S., Joossens J., Van Der Veken P., et al. (2018). Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome. Br. J. Pharmacol. 175 (17), 3516–3533. 10.1111/bph.14396 PubMed Abstract | 10.1111/bph.14396 | Google Scholar - DOI - DOI - PMC - PubMed
    1. Chen L., Keller L. J., Cordasco E., Bogyo M., Lentz C. S. (2019). Fluorescent triazole urea activity-based probes for the single-cell phenotypic characterization of Staphylococcus aureus . Angew. Chem. Int. Ed. 58 (17), 5643–5647. 10.1002/anie.201900511 PubMed Abstract | 10.1002/anie.201900511 | Google Scholar - DOI - DOI - PMC - PubMed
    1. Svarcbahs R., Julku U., Kilpeläinen T., Kyyrö M., Jäntti M., Myöhänen T. T., et al. (2019). New tricks of prolyl oligopeptidase inhibitors - a common drug therapy for several neurodegenerative diseases. Biochem. Pharmacol. 161, 113–120. 10.1016/j.bcp.2019.01.013 PubMed Abstract | 10.1016/j.bcp.2019.01.013 | Google Scholar - DOI - DOI - PubMed
    1. Zerimech F., Jourdain M., Onraed B., Bouchecareilh M., Sendid B., Duhamel A., et al. (2021). Protease-antiprotease imbalance in patients with severe COVID-19. Clin. Chem. Lab. Med. 59 (8), e330–e334. 10.1515/cclm-2021-0137 PubMed Abstract | 10.1515/cclm-2021-0137 | Google Scholar - DOI - DOI - PubMed

Publication types

LinkOut - more resources